Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A product and fusion protein for treating and/or preventing beta hemoglobinopathies

A fusion protein and purpose technology, applied in the field of genetic engineering, can solve limited problems

Active Publication Date: 2022-04-08
EAST CHINA NORMAL UNIV +1
View PDF9 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

These methods all improve their efficiency to a certain extent, but are relatively limited.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A product and fusion protein for treating and/or preventing beta hemoglobinopathies
  • A product and fusion protein for treating and/or preventing beta hemoglobinopathies
  • A product and fusion protein for treating and/or preventing beta hemoglobinopathies

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0055] The present invention will be described in further detail in conjunction with the following specific examples and accompanying drawings, and the protection content of the present invention is not limited to the following examples. Without departing from the spirit and scope of the inventive concept, changes and advantages conceivable by those skilled in the art are all included in the present invention, and the appended claims are the protection scope. The process, conditions, reagents, experimental methods, etc. for implementing the present invention are general knowledge and common knowledge in the art except for the content specifically mentioned below, and the present invention has no special limitation content. As described in Sambrook et al., Molecular Cloning, A Laboratory Manual (New York: Cold Spring Harbor Laboratory Press, 1989), or according to the manufacturer's suggested conditions.

[0056] 1. Working characteristics of fusion protein hyeA3A-BE4max

[00...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The application discloses a product and fusion protein for treating and / or preventing beta hemoglobinopathies. The fusion protein includes the DNA binding domain of Rad51, a mutant of cytosine deaminase APOBEC3A and a nuclease; Amide mutation to glycine. The product includes the coding gene of the fusion protein and the delivery vector of sgRNA, and the sgRNA guides the fusion protein to perform single-base gene editing on the promoter regions of HBG1 and HBG2 in target cells. This application can greatly improve the efficiency of single-base gene editing, more precisely and efficiently target HBG1 and HBG2 promoter regions -117 to generate mutations from G to A, thereby activating the expression of γ-globin, and providing clinical treatment for β-hemoglobin The disease provides a more precise and efficient treatment strategy.

Description

technical field [0001] The invention relates to the technical field of genetic engineering, in particular to a product and fusion protein for treating and / or preventing beta hemoglobinopathies. Background technique [0002] Since 2013, a new generation of gene editing technology represented by CRISPR / Cas9 has entered various experiments in the field of biology, changing the traditional means of gene manipulation. In April 2016, David Liu's laboratory first reported the single-base gene editing technology. After that, other types of single-base gene editing technology based on the principle of cytosine deaminase (such as cytosine deaminase from lamprey and human) Ammases are fused to dCas9 or Cas9n in different ways) have also been reported successively. It uses CRISPR / Cas9 derived from Streptococcus pyogenes (Streptococcus pyogenes) spCas9 uses NGG as PAM (spacer precursor adjacent motif) and recognizes and specifically binds DNA upstream of NGG to achieve a single base fro...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Patents(China)
IPC IPC(8): C07K19/00C12N15/62C12N15/113C12N15/85C12N5/10A61K38/50A61P7/06A61K38/46
CPCC12N9/78C12N9/16C12Y305/04001C12N15/113C12N15/85A61K38/50A61K38/465A61P7/06C07K2319/80C12N2310/10A61K2300/00
Inventor 李大力朱碧云张晓辉刘明耀
Owner EAST CHINA NORMAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com